Sign in to view content

Treatment of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy With Intravitreal Aflibercept Injection: 52-Week Results From PANORAMA

W. Lloyd Clark, MD, FASRS

Video
Published 2019

W. Lloyd Clark, MD

Diabetic Retinopathy Part I Symposium

Related

Diabetic Retinal Telescreening Program in a High-Risk Population Highlights Significant Rates of Retinal Pathology
Matthew P. Ohr, MD
Annual Meeting Talks
2020
Are There Safety Concerns With Bevacizumab for ROP
Robert L. Avery, MD
Updates from the Field
2017
Port Delivery System With Ranibizumab: Key Outcomes From the Ladder Phase 2 Trial That Supported Archway Phase 3 Study Design
Arshad M. Khanani, MD, MA, FASRS
Annual Meeting Talks
2019

Category: Diabetic Retinopathy

See more